InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the complete record of transactions filed by Drapkin Kimberlee C, Chief Financial Officer. Director active across 1 companies, notably Jounce Therapeutics, Inc.. Aggregated, 4 filings have been published. Total volume traded: €59k. The latest transaction was filed on 1 February 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
027,500 shares0
Common Stock
SEC:0001640455-22-000018:0·
027,500 shares0
Common Stock
SEC:0001640455-22-000018·
€29,6934,595 shares@ €6.462100.0% of flow
Common Stock
SEC:0001640455-22-000009·
€29,6934,595 shares@ €6.46250.0% of flow
Common Stock
SEC:0001640455-22-000009:0·
4 of 4 declarations
About Drapkin Kimberlee C
Kimberlee C. Drapkin is the CFO and Treasurer at Jounce Therapeutics, Inc. She oversees the financial functions of the company, ensuring compliance and effective management of financial resources. Her expertise is essential for strategic planning and decision-making.
